When Simple Messages Can Make a Real Difference

Lyndah DreilingWe were thrilled that the CDC Foundation asked us to assist CDC on a campaign to help reduce infections in cancer patients. It’s a perfect opportunity for two organizations with complimentary expertise to join forces and leverage each other’s strengths for the benefit of patients.

At Amgen, we are focused on science and communicating that science to medical practitioners. CDC has expertise in translating science for the public in a way that is easy to understand, yet extremely credible. We’re bringing these capabilities together to develop tools and resources to help healthcare providers, cancer patients and families better understand and reduce the risk of infection that often accompanies aggressive chemotherapy. Studies show that 10 percent of cancer patients undergoing treatment end up hospitalized due to infection – and every two hours a patient dies from this complication.

The great thing about this type of program is that it opens new doors for a company like ours. CDC has relationships outside of the medical community that will enable us to get these health messages out to the community more quickly. And quite simply, they do exceptional work, so we’re proud to be affiliated with them.

Learn more about the campaign: preventcancerinfections.org

Dr. Lyndah Dreiling is vice president, global development, hematology/oncology for Amgen, a biotechnology company that develops medicines to help fight cancer, rheumatoid arthritis and other serious illnesses.